HBV-IN-54
HBV-IN-54 is a selective and orally active HBV inhibitor. HBV-IN-54 exhibits anti-HBV activity in both HepAD38 cells (EC50 = 0.020 μM, CC50 > 100 μM) and HLCZ01 cells (EC50 = 0.024 μM, CC50 > 100 μM) . HBV-IN-54 inhibits viral replication in vivo. HBV-IN-54 displays favorable physicochemical properties and high plasma stability. HBV-IN-54 can be used for research on Hepatitis B (HBV) [1].
Product Specifications
UNSPSC
12352005
Target
HBV
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
CC1=C(C=C(C(F)=C1)NC(N2CCN(CC2)CCO)=S)C(NC3=CC(C)=C(C=C3)F)=O
Molecular Formula
C22H26F2N4O2S
Molecular Weight
448.53
References & Citations
[1]Liang M, et al. Multisite Occupancy and Multidimensional Optimization: Design and Evaluation of Piperazine-Thioureidobenzamide Derivatives as Potent HBV Capsid Assembly Modulators. J Med Chem. 2025 Nov 27;68 (22) :24358-24380.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY432595 100 µg
TMEM239 (NM_001167670) Human Over-expression Lysate
Sign In for Pricing
View Details 
KN205288BN 1 Kit
MCSF Receptor (CSF1R) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 
BNC942272-100 1x 100 µL
PDZ and LIM Domain 1 (CPTC-PDLIM1-1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details